⌘K

Login Start Free

Home/Filings/4/0001127602-21-004042

4//SEC Filing

Avruch Steven 4

Accession 0001127602-21-004042

CIK 0001681087other

View on SEC.gov Company Profile

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 5:55 PM ET

Size

5.2 KB

Accession

0001127602-21-004042

Insider Transaction Report

Form 4

Period: 2021-02-04

AVROBIO, Inc.AVRO

VP & General Counsel

Transactions

Award
Stock Option (Right to Buy)
2021-02-04+98,200→ 98,200 total
Exercise: $16.02Exp: 2031-02-03→ Common Stock (98,200 underlying)

Footnotes (1)

[F1]25% of the shares shall vest and become exercisable on February 4, 2022, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

AVROBIO, Inc.

CIK 0001681087

Entity typeother

Related Parties

1

filerCIK 0001762236

Filing Metadata

Form type: 4
Filed: Feb 3, 7:00 PM ET
Accepted: Feb 4, 5:55 PM ET
Size: 5.2 KB

View on SEC.gov